Shanghai Sigma Audley SSA
Finnrick has tested 224 samples from Shanghai Sigma Audley SSA across 14 products.
Fraud: Based on community reports, we have identified sigmaaudley.site as a fraudulent web site aggressively operating in the name of this vendor. It is most likely entirely unaffiliated with the original company, the fraud is putting the public at risk, so we are temporarily putting all tests under review.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| BPC-157 | 13 | 3 Jul 2025 | 19 Jan 2026 | |||||
| Cagrilintide | 10 | 29 Jun 2025 | 7 Jan 2026 | |||||
| CJC-1295 | 4 | 31 Jul 2025 | 23 Oct 2025 | |||||
| GHK-Cu | 11 | 4 Aug 2025 | 5 May 2026 | |||||
| Ipamorelin | 8 | 9 Jun 2025 | 20 Feb 2026 | |||||
| Melanotan II | 4 | 4 Sep 2025 | 29 Mar 2026 | |||||
| PT-141 | 5 | 1 Sep 2025 | 23 Oct 2025 | |||||
| Retatrutide | 82 | 9 Jun 2025 | 5 May 2026 | |||||
| Semaglutide | 10 | 29 Jun 2025 | 3 Mar 2026 | |||||
| Sermorelin | 8 | 10 Jul 2025 | 20 Feb 2026 | |||||
| TB-500 | 3 | 24 Jul 2025 | 9 Sep 2025 | |||||
| Tesamorelin | 22 | 9 Jun 2025 | 19 Mar 2026 | |||||
| Tirzepatide | 44 | 20 Jun 2025 | 6 May 2026 | |||||
The Shanghai Sigma Audley SSA samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Shanghai Sigma Audley SSA tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 May 2026⚠️ | Tirzepatide | View | 30mg | 28mg | -6.7% | 99.90% | Jun092025 | White Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 5 May 2026⚠️ | GHK-Cu | View | 100mg | 77mg | -23.0% | 99.90% | (no batch ID) | No Label / Gold Crimp / Clear Cap | Lab E | Public | |
| 5 May 2026⚠️ | Retatrutide | View | 5mg | 4.08mg | -18.4% | 99.90% | 41528 | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 29 Mar 2026⚠️ | Melanotan II | View | 10mg | 11.8mg | +18.0% | 99.90% | June 29 2025 | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 25 Mar 2026⚠️ | Tirzepatide | View | 30mg | 12.1mg | -59.7% | 99.90% | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab G | Public | |
| 25 Mar 2026⚠️ | Tirzepatide | View | 15mg | 10.6mg | -29.3% | 99.80% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 19 Mar 2026⚠️ | Retatrutide | View | 15mg | 16.3mg | +8.7% | 99.90% | SART1520250728F | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
About Shanghai Sigma Audley SSA Test Results From Finnrick
Shanghai Sigma Audley SSA is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 14 products and 224 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Shanghai Sigma Audley SSA Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for Shanghai Sigma Audley SSA, and 4 in the past three months. The overall dataset includes 224 tested samples with an average score of 7.0/10 across all products.
Across 224 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.7%. Approximately 91% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (82 tests, 99% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 7.4/10), suggesting significant batch-to-batch differences.
- Tirzepatide (44 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 2.3 to 10.0 (average 6.9/10), suggesting significant batch-to-batch differences.
- GHK-Cu (11 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 5.0 to 9.8 (average 7.4/10), suggesting significant batch-to-batch differences.